Talking Rheumatology Research
By British Society for Rheumatology
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by British Society for Rheumatology
Category: Medicine
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 2
Reviews: 0
Episodes: 43
Description
Discover the latest research from Rheumatology, Rheumatology Advances in Practice, and beyond.
| Episode | Date |
|---|---|
|
Ep. 43 The metaverse: a new frontier for rheumatology
|
Apr 10, 2024 |
|
Ep 42. Combination therapy or autologous hematopoietic stem cell transplantation for patients with progressive systemic sclerosis?
|
Jan 11, 2024 |
|
Ep 41. Addressing the leaky pipeline
|
Jan 04, 2024 |
|
Ep 40. New Editor-in-Chief: Introducing Prof Ernest Choy
|
Dec 21, 2023 |
|
Ep 39. UK JIA Biologics Register: stopping biologics for remission
|
Nov 30, 2023 |
|
Ep 38. Is risankizumab safe and effective for active psoriatic arthritis? Results from the KEEPsAKE 2 study
|
Oct 26, 2023 |
|
Ep 37. Can MSUS and RADAI-F5 help to identify RA patients at risk of poor functional and radiological outcomes?
|
Oct 18, 2023 |
|
Ep 36. Trainee Publishing Programme 2023: Dr Charlotte Sharp & Karen Staniland
|
Oct 11, 2023 |
|
Ep 35. Trainee Publishing Programme 2023: Dr Pallavi Shamdasani
|
Oct 04, 2023 |
|
Ep 34. Trainee Publishing Programme 2023: Dr Shivani Gor & Dr Sung-Hee Kim
|
Sep 27, 2023 |
|
Ep 33. Trainee Publishing Programme 2023: Dr Lauren Huckerby
|
Sep 20, 2023 |
|
Ep 32. Trainee Publishing Programme 2023: Dr Cristiana Sieiro Santos
|
Sep 13, 2023 |
|
Ep 31. Are AAV patients at an increased risk of stroke?
|
Sep 06, 2023 |
|
Ep 30. Diagnosing cocaine-induced vasculitis
|
Aug 30, 2023 |
|
Ep 29. Does vaccination against SARS-CoV-2 infection cause adverse events among SLE patients?
|
Aug 03, 2023 |
|
Ep 28. Does ultrasound-defined tenosynovitis and synovitis aid the prediction of persistent arthritis?
|
Jul 06, 2023 |
|
Ep 27. Is secukinumab safe and effective in ankylosing spondylitis?
|
Jun 08, 2023 |
|
Ep 26. Dr Polly Livermore and Heather Rostron discuss their future research plans
|
Jun 01, 2023 |
|
Ep 25. How does symptom duration before DMARD therapy impact the costs of RA?
|
Apr 27, 2023 |
|
Ep 24. Risk of myocardial infarction among RA patients receiving IL6 or TNF inhibitors
|
Apr 27, 2023 |
|
Ep 23. The long-term use of tocilizumab in giant cell arteritis
|
Mar 31, 2023 |
|
Ep 22. The top 10 research priorities in psoriatic arthritis
|
Mar 30, 2023 |
|
Ep 21. Ultrasonography in the prediction of gout flares
|
Mar 16, 2023 |
|
Ep 20. Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in juvenile-onset IRDs
|
Feb 09, 2023 |
|
Ep 19. A new autoantibody associated with anti-synthetase syndrome
|
Jan 26, 2023 |
|
Ep 18. Long-term use of glucocorticoids for polymyalgia rheumatica
|
Jan 19, 2023 |
|
Ep 17. Patient-led smartphone images show progression of SSc-related digital ulcers
|
Jan 12, 2023 |
|
Ep 16. Celebrating women in rheumatology
|
Dec 15, 2022 |
|
Ep 15. Experiences of delivering interventions for fatigue
|
Dec 08, 2022 |
|
Ep 14. Educational attainment and clinically suspect arthralgia
|
Oct 05, 2022 |
|
Ep 13. Reduced cognitive ability in RA
|
Aug 24, 2022 |
|
Ep 12. Precision medicine in autoimmune diseases
|
Aug 17, 2022 |
|
Ep 11. Air pollution and RA flares
|
Aug 03, 2022 |
|
Ep 10. The controversial argument for glucocorticoids and bone health
|
Jul 06, 2022 |
|
Ep 9. Phase 2 trial of dapirolizumab pegol in SLE
|
Jun 16, 2022 |
|
Ep 8. Risk of VTE associated with tofacitinib in RA
|
Jun 01, 2022 |
|
Ep 7. Ultrasound imaging sub-phenotypes in PsA
|
May 25, 2022 |
|
Ep 4. De novo lupus nephritis and belimumab
|
Apr 22, 2022 |
|
Ep 5. VEXAS syndrome
|
Apr 22, 2022 |
|
Ep 6. Scoring SLE with the Easy-BILAG
|
Apr 22, 2022 |
|
Ep 2. Improving outcomes for hospitalised gout patients
|
Apr 22, 2022 |
|
Ep 3. Cytokine storm syndromes
|
Apr 22, 2022 |
|
Ep 1. CT-P13 and the PERSIST study
|
Apr 22, 2022 |